NEUP (Neuphoria Therapeutics) Total Payout Yield %: -92.34 (As of Jul. 08, 2026)


NEUP Neuphoria Therapeutics Inc NEUP
28 GF Score
Price $3.59
! 1 Warning Sign
View Full Analysis

What is Neuphoria Therapeutics Total Payout Yield %?

Neuphoria Therapeutics NEUP +4.36% 28 Total Payout Yield % is -92.34 as of Jul. 08, 2026. GuruFocus rates NEUP with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Neuphoria Therapeutics's current Total Payout Yield % is -92.34%.

Neuphoria Therapeutics Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

Neuphoria Therapeutics Total Payout Yield % Related Terms

Neuphoria Therapeutics Total Payout Yield % Historical Data

* Premium members only.

The historical data trend for Neuphoria Therapeutics's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuphoria Therapeutics Total Payout Yield % Chart

Neuphoria Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Payout Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.02 -0.01 -0.55 -10.88

Neuphoria Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -46.82 -281.11 0.00

NEUP vs PLRZ, SKYE, IGC: Total Payout Yield % Comparison

For the Biotechnology subindustry, Neuphoria Therapeutics's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuphoria Therapeutics Total Payout Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuphoria Therapeutics's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Neuphoria Therapeutics's Total Payout Yield % falls into.


NEUP
28GF Score
Neuphoria Therapeutics Inc NEUP
Total Payout Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuphoria Therapeutics Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Neuphoria Therapeutics's Total Payout Yield % for the fiscal year that ended in Jun. 2025 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 1.528 + 0) / 14.0438
=-10.88%

Neuphoria Therapeutics's annualized Total Payout Yield % for the quarter that ended in Mar. 2026 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 21.88439
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Yield % →
What does a Total Payout Yield % of -92.34 mean?
Neuphoria Therapeutics (NEUP) has a Total Payout Yield % of -92.34 as of Jul. 08, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Neuphoria Therapeutics and its competitors.
Is Neuphoria Therapeutics' Total Payout Yield % too high?
Neuphoria Therapeutics' current Total Payout Yield % is -92.34. Overall, Neuphoria Therapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Neuphoria Therapeutics' Total Payout Yield % compare to PLRZ and SKYE?
Neuphoria Therapeutics' Total Payout Yield % of -92.34 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Biotechnology company?
A good Total Payout Yield % depends on the Biotechnology industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Neuphoria Therapeutics and its competitors. Neuphoria Therapeutics's current Total Payout Yield % is -92.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuphoria Therapeutics stock overvalued right now?
Neuphoria Therapeutics (NEUP) has a current Total Payout Yield % of -92.34. The current Total Payout Yield % is -92.34. Neuphoria Therapeutics' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For Neuphoria Therapeutics (NEUP), the current Total Payout Yield % is -92.34 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuphoria Therapeutics Business Description

Address 100 Summit Drive, Burlington, MA, USA, 01803
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
28GF Score

Get the complete analysis for NEUP

Total Payout Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.59
Price